Does preoperative HDL-C predict Later Cardiovascular Events after Abdominal Aortic Aneurysm Surgery?
Patients at high risk for later cardiovascular events should require a careful follow-up and may also require an aggressive lipid-modifying therapy.
Taken together these results show that rapamycin-induced FOXO1 inactivation reduces the antitumor efficacy of rapamycin.